Morrow M - Search Results

1

Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.

Perez CA, Zumsteg ZS, Gupta G, Morrow M, Arnold B, Patil SM, Traina TA, Robson ME, Wen YH, McCormick B, Powell SN, Ho AY. Perez CA, et al. Among authors: morrow m. Breast Cancer Res Treat. 2013 Jun;139(2):497-506. doi: 10.1007/s10549-013-2550-x. Epub 2013 May 5. Breast Cancer Res Treat. 2013. PMID: 23645006

2

Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma.

Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, Wilson JF, Winchester D. Morrow M, et al. J Clin Oncol. 2001 Apr 15;19(8):2254-62. doi: 10.1200/JCO.2001.19.8.2254. J Clin Oncol. 2001. PMID: 11304779

3

Compliance with breast-conservation standards for patients with early-stage breast carcinoma.

White J, Morrow M, Moughan J, Owen J, Pajak T, DesHarnais S, Winchester DP, Wilson JF; American College of Surgeons Commission on Cancer; American College of Radiology Patterns of Care Study. White J, et al. Among authors: morrow m. Cancer. 2003 Feb 15;97(4):893-904. doi: 10.1002/cncr.11141. Cancer. 2003. PMID: 12569588 Free article.

4

Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer.

O'Regan RM, Von Roenn JH, Carlson RW, Malik U, Sparano JA, Staradub V, Khan S, Jovanovic B, Morrow M, Gradishar WJ. O'Regan RM, et al. Among authors: morrow m. Clin Breast Cancer. 2005 Jun;6(2):163-8. doi: 10.3816/CBC.2005.n.019. Clin Breast Cancer. 2005. PMID: 16001995 Clinical Trial.

5

Limiting breast surgery to the proper minimum.

Morrow M. Morrow M. Breast. 2005 Dec;14(6):523-6. doi: 10.1016/j.breast.2005.08.008. Epub 2005 Sep 16. Breast. 2005. PMID: 16169222 Review.

6

Correlates of breast reconstruction: results from a population-based study.

Morrow M, Mujahid M, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D, Salem B, Lakhani I, Katz SJ. Morrow M, et al. Cancer. 2005 Dec 1;104(11):2340-6. doi: 10.1002/cncr.21444. Cancer. 2005. PMID: 16216000 Free article.

7

Selecting patients for breast-conserving therapy: the importance of lobular histology.

Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA. Morrow M, et al. Cancer. 2006 Jun 15;106(12):2563-8. doi: 10.1002/cncr.21921. Cancer. 2006. PMID: 16683225 Free article.

8

Surgical aspects of inflammatory breast cancer.

Kell MR, Morrow M. Kell MR, et al. Among authors: morrow m. Breast Dis. 2005-2006;22:67-73. doi: 10.3233/bd-2006-22108. Breast Dis. 2005. PMID: 16735788 Review.

9

The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.

O'Sullivan MJ, Li T, Freedman G, Morrow M. O'Sullivan MJ, et al. Among authors: morrow m. Ann Surg Oncol. 2007 Nov;14(11):3133-40. doi: 10.1245/s10434-007-9523-4. Epub 2007 Jul 26. Ann Surg Oncol. 2007. PMID: 17653798

10

alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.

Ivanov O, Chen F, Wiley EL, Keswani A, Diaz LK, Memmel HC, Rademaker A, Gradishar WJ, Morrow M, Khan SA, Cryns VL. Ivanov O, et al. Among authors: morrow m. Breast Cancer Res Treat. 2008 Oct;111(3):411-7. doi: 10.1007/s10549-007-9796-0. Epub 2007 Oct 30. Breast Cancer Res Treat. 2008. PMID: 17968656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,263 results

Search Page

Filters